About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,015 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,015 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2641-2660 of 13,015 trials

CompletedFluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerThis phase I trial studies how well fluciclovine positron emission tomography (PET)/computed tomography (CT) and PSMA PET/CT work in helping doctors understand and classify…NCT04750473·Atlanta, Georgia TerminatedVITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant OrganismsThis randomized, open-label, clinical study aims to explore the safety and tolerability of KB109, a novel glycan, versus an observational control group on the gut microbiome in…NCT03944369·Torrance, California and 7 others Active not recruitingErlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung CancerThis randomized phase II trial studies how well giving erlotinib hydrochloride and cabozantinib-s-malate alone or in combination works as second or third line therapy in treating…NCT01708954·Scottsdale, Arizona and 355 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedPosiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's PatientsAnnovis is conducting a clinical study to investigate Posiphen in patients with Early Alzheimer's Disease (AD) and Early Parkinson's Disease (PD).NCT04524351·Stamford, Connecticut and 12 others

CompletedSPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainThe purpose of this study is to determine the benefit and safety of relugolix 40 milligrams (mg) once daily, co-administered with low-dose estradiol (E2) and norethindrone acetate…NCT03204331·Andalusia, Alabama and 90 others

Active not recruitingDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)NCT04567420·Tucson, Arizona and 18 others

CompletedA 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced ConstipationThe purpose of this study is to evaluate the effect and safety of NKTR-118 treatment of opioid-induced constipation in patients with non-cancer-related pain over a 6-month period.NCT01395524·Birmingham, Alabama and 115 others

CompletedA Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL RegaTo determine the effect of HIV-1 immunogen (Remune) on AIDS-free survival, defined as the time prior to development of an AIDS-defining condition or death.NCT00002359·Phoenix, Arizona and 53 others

CompletedEffect of Aging on Cortical Excitability and Motor LearningThe objective of the current proposal is to identify 1) how aging-related changes in GABAergic cortical inhibition affect motor performance, and 2) how aerobic exercise may…NCT03750903·Decatur, Washington

CompletedAn Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.This study provided access to pasireotide sc in patients with Cushing's disease.and provided additional information for safety and efficacy of pasireotide s.c.NCT01582061·Peoria, Arizona and 64 others

RecruitingMassed Prolonged Exposure for PTSD in Substance Use TreatmentThe goal of this clinical trial is to learn if receiving Prolonged Exposure Therapy for PTSD in massed format (multiple sessions weekly) is as effective as receiving it with…NCT06296186·San Diego, California and 5 others

CompletedPharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 TrialThis study is conducted globally. This study describes pharmacogenetic testing of saliva samples from patients who participated in the NN1731-3562 trial (adept™2) (NCT01392547).NCT02541942·Tucson, Arizona and 14 others

TerminatedA Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum TherapyThe study consists of a Phase1b lead-in portion to determine the maximum tolerated dose (MTD) of OMP-59R5 (tarextumab) in combination with etoposide (EP) for 6 cycles followed a…NCT01859741·Rogers, Arkansas and 34 others

CompletedEfficacy of Caregiver Training Program in Enhancing Caregiver and Patient OutcomesAs part of Phase II of the NIH SBIR grant, the study will conduct a randomized controlled clinical trial in which the MapHabit system (MHS) will offer a caregiver training product…NCT05527405·Atlanta, Georgia

CompletedSafety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)To assess the long-term safety and tolerability of oral OPC-34712 (brexpiprazole), given in addition to an FDA approved antidepressant (ADT) for the treatment of adults with Major…NCT01360866·Birmingham, Alabama and 141 others

TerminatedEfficacy of Flomax to Improve Stone Passage Following Shock Wave LithotripsyThe majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.NCT00209131·Atlanta, Georgia

CompletedA Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentThe purpose of this study is to determine the value of changing anti-HIV medications in children with progressive HIV disease who have received previous treatment.NCT00000902·Birmingham, Alabama and 61 others

CompletedThe MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPIThe overall goal of this project is to compare the absolute quantification of myocardial perfusion done by using CT myocardial perfusion imaging (CT-MPI) and the coronary flow…NCT04316676·Atlanta, Georgia

CompletedComputer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003417·Birmingham, Alabama and 236 others

TerminatedCvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line TreatmentAs \< 10% of the necessary patients required by the protocol were recruited and the data were not intended to support a labeling claim, it was determined that the abbreviated…NCT01521143·Los Angeles, California and 7 others

PreviousPage 133 of 651Next

in Atlanta

Heart Diseasein Atlanta